USFDA issues ‘DMF information request’ to SMS Pharmaceuticals

17 Sep 2019 Evaluate

US Food and Drug Administration (USFDA) has issued a ‘DMF information request’ to SMS Pharmaceuticals to provide the information to demonstrate its Ranitidine API manufacturing process does not contain NDMA impurity.

SMS Pharmaceuticals is a global player in API manufacturing having strong research and manufacturing team supported by state of art facilities.

SMS Pharmaceuticals Share Price

208.35 5.85 (2.89%)
16-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1536.95
Dr. Reddys Lab 6038.00
Cipla 1384.30
Zydus Lifesciences 937.80
Lupin 1613.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.